Overview
Humanin is a small mitochondrial-derived peptide, meaning it is encoded within mitochondrial DNA rather than the nuclear genome. This unusual origin has made it a compound of particular interest as a tool for studying signaling that arises from the mitochondria themselves.
In preclinical and in-vitro systems, humanin has been studied for cytoprotective signaling and for metabolic pathways relevant to cellular aging. Researchers investigating mitochondrial biology and stress responses have used it as a research material to probe how mitochondrial-derived peptides participate in cellular signaling.
What makes humanin a notable entry for a longevity catalog is its place within the emerging class of mitochondrial-derived peptides, a category that has reframed how investigators think about the mitochondrion as a signaling source. Whether these mechanisms translate to female physiology remains an open research question; our evidence review tracks how many of the underlying studies included women. Supplied for laboratory research use only.
Summary
Humanin is a mitochondrial-derived peptide studied for cytoprotective and metabolic roles in aging. The evidence is preclinical and observational (circulating levels in humans); there are no controlled therapeutic trials and no female-specific outcome data.
Evidence in women
Mechanism
A small mitochondrial-genome-encoded peptide proposed to protect cells from apoptosis and modulate metabolic and inflammatory signaling.
Free research guide
How to tell real female data from male-extrapolated claims, with the questions to ask about any compound.
Citations (PMID)
Related peptides
Educational information for laboratory and research use only. Not medical advice, a recommendation, or a claim of safety or efficacy; no personal dosing. “Unstudied” means no qualifying study was found, not that a compound is safe or unsafe.